DNA Damage Clustering after Ionizing Radiation and Consequences in the Processing of Chromatin Breaks.
ATM
ATR
DNA damage response
charged-particle radiotherapy
complex double-strand breaks
double-strand break clusters
double-strand breaks
heavy ions
high-LET ionizing radiation
ionizing radiation
protons
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
24 Feb 2022
24 Feb 2022
Historique:
received:
31
01
2022
revised:
21
02
2022
accepted:
22
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Charged-particle radiotherapy (CPRT) utilizing low and high linear energy transfer (low-/high-LET) ionizing radiation (IR) is a promising cancer treatment modality having unique physical energy deposition properties. CPRT enables focused delivery of a desired dose to the tumor, thus achieving a better tumor control and reduced normal tissue toxicity. It increases the overall radiation tolerance and the chances of survival for the patient. Further improvements in CPRT are expected from a better understanding of the mechanisms governing the biological effects of IR and their dependence on LET. There is increasing evidence that high-LET IR induces more complex and even clustered DNA double-strand breaks (DSBs) that are extremely consequential to cellular homeostasis, and which represent a considerable threat to genomic integrity. However, from the perspective of cancer management, the same DSB characteristics underpin the expected therapeutic benefit and are central to the rationale guiding current efforts for increased implementation of heavy ions (HI) in radiotherapy. Here, we review the specific cellular DNA damage responses (DDR) elicited by high-LET IR and compare them to those of low-LET IR. We emphasize differences in the forms of DSBs induced and their impact on DDR. Moreover, we analyze how the distinct initial forms of DSBs modulate the interplay between DSB repair pathways through the activation of DNA end resection. We postulate that at complex DSBs and DSB clusters, increased DNA end resection orchestrates an increased engagement of resection-dependent repair pathways. Furthermore, we summarize evidence that after exposure to high-LET IR, error-prone processes outcompete high fidelity homologous recombination (HR) through mechanisms that remain to be elucidated. Finally, we review the high-LET dependence of specific DDR-related post-translational modifications and the induction of apoptosis in cancer cells. We believe that in-depth characterization of the biological effects that are specific to high-LET IR will help to establish predictive and prognostic signatures for use in future individualized therapeutic strategies, and will enhance the prospects for the development of effective countermeasures for improved radiation protection during space travel.
Identifiants
pubmed: 35268641
pii: molecules27051540
doi: 10.3390/molecules27051540
pmc: PMC8911773
pii:
doi:
Substances chimiques
Chromatin
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Federal Ministry of Education and Research
ID : 03NUK005C
Organisme : Federal Ministry of Education and Research
ID : 02NUK043B, COLLAR
Organisme : Bundesministerium für Wirtschaft und Technologie
ID : BMWi: ESA-AO-IBER-2017, 50WB1836
Références
Cancer Res. 1958 Feb;18(2):121-34
pubmed: 13511365
Mutat Res. 2011 Jun 3;711(1-2):61-72
pubmed: 21329706
Radiat Oncol. 2015 Aug 19;10:175
pubmed: 26286029
Radiat Res. 2008 Jun;169(6):649-59
pubmed: 18494540
Int J Radiat Biol. 1994 Nov;66(5):531-6
pubmed: 7983441
Nat Rev Clin Oncol. 2022 Feb;19(2):114-131
pubmed: 34819622
Cancers (Basel). 2021 Dec 22;14(1):
pubmed: 35008196
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):175-81
pubmed: 24239385
Front Oncol. 2016 Mar 29;6:64
pubmed: 27064200
Radiat Res. 2011 Jul;176(1):25-37
pubmed: 21466383
Nanoscale. 2018 Jan 18;10(3):1162-1179
pubmed: 29271466
Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Sep;36(3):241-7
pubmed: 159268
Int J Radiat Biol. 1990 Jun;57(6):1141-50
pubmed: 1971840
Annu Rev Biochem. 2008;77:229-57
pubmed: 18275380
Front Oncol. 2020 Aug 14;10:1396
pubmed: 32923391
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8293-8
pubmed: 21527720
Nucleic Acids Res. 1998 Apr 1;26(7):1653-9
pubmed: 9512535
Int J Radiat Biol. 2009 Nov;85(11):1051-9
pubmed: 19895282
Nat Commun. 2020 May 8;11(1):2320
pubmed: 32385320
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Radiat Res. 1997 Dec;148(6):561-7
pubmed: 9399701
Genome Integr. 2013 Mar 22;4(1):1
pubmed: 23522792
Adv Drug Deliv Rev. 2021 Dec;179:114018
pubmed: 34688685
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):656-665
pubmed: 30851349
Radiat Res. 1998 Jun;149(6):533-42
pubmed: 9611091
Radiat Res. 1994 May;138(2):291-6
pubmed: 8184001
Nat Rev Mol Cell Biol. 2020 Dec;21(12):765-781
pubmed: 33077885
Nucleic Acids Res. 2005 Jan 14;33(1):422-9
pubmed: 15653642
Int J Oncol. 2017 Oct;51(4):1124-1134
pubmed: 28849129
Nat Commun. 2014 Jul 03;5:4286
pubmed: 24989324
J Cell Biochem. 2004 Jul 1;92(4):781-94
pubmed: 15211575
Nat Commun. 2018 Jun 27;9(1):2484
pubmed: 29950655
Confin Neurol. 1962;22:183-9
pubmed: 14033248
Nucleic Acids Res. 2020 Feb 28;48(4):1905-1924
pubmed: 31832684
Microbiol Mol Biol Rev. 1999 Jun;63(2):349-404
pubmed: 10357855
Cancer Sci. 2021 Jul;112(7):2563-2577
pubmed: 33990993
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):112-119
pubmed: 26254681
Science. 2003 Jun 6;300(5625):1542-8
pubmed: 12791985
Radiat Res. 2014 Sep;182(3):338-44
pubmed: 25117625
Life (Basel). 2021 Jun 14;11(6):
pubmed: 34198619
J Biol Chem. 2004 Apr 2;279(14):13634-9
pubmed: 14734547
Nat Rev Mol Cell Biol. 2003 Jun;4(6):435-45
pubmed: 12778123
Br J Cancer Suppl. 1987 Jun;8:105-12
pubmed: 2820457
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
Int J Radiat Biol. 2000 Sep;76(9):1179-87
pubmed: 10993629
DNA Repair (Amst). 2015 Jan;25:72-83
pubmed: 25497328
Radiat Res. 1996 Feb;145(2):188-99
pubmed: 8606929
Radiat Res. 2010 Jan;173(1):27-39
pubmed: 20041757
Radiat Res. 2012 Nov;178(5):385-94
pubmed: 22998227
Nucleic Acids Res. 2013 Sep;41(16):7589-605
pubmed: 23804754
Cancers (Basel). 2019 Oct 28;11(11):
pubmed: 31661831
Radiat Oncol. 2013 Apr 02;8:77
pubmed: 23547740
J Radiat Res. 2011;52(3):309-19
pubmed: 21628845
Int J Radiat Biol. 2006 Apr;82(4):293-305
pubmed: 16690597
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Adv Drug Deliv Rev. 2017 Jan 15;109:26-44
pubmed: 27919760
Annu Rev Biochem. 2015;84:711-38
pubmed: 25580527
Genes (Basel). 2021 Aug 31;12(9):
pubmed: 34573351
Med Phys. 2010 Sep;37(9):4874-9
pubmed: 20964205
Nucleic Acids Res. 2016 Sep 19;44(16):7673-90
pubmed: 27257076
Antioxid Redox Signal. 2014 Jul 10;21(2):218-20
pubmed: 24702164
Radiat Res. 2014 Sep;182(3):282-91
pubmed: 25098728
Nucleic Acids Res. 2003 Sep 15;31(18):5377-88
pubmed: 12954774
Cancer Sci. 2008 Jul;99(7):1455-60
pubmed: 18422753
Trends Genet. 2016 Sep;32(9):566-575
pubmed: 27450436
Trends Genet. 2008 Nov;24(11):529-38
pubmed: 18809224
Radiother Oncol. 2015 Sep;116(3):366-73
pubmed: 26303013
DNA Repair (Amst). 2014 Jul;19:176-81
pubmed: 24767945
Cancer Res. 2005 May 15;65(10):4020-30
pubmed: 15899791
Annu Rev Genet. 2010;44:113-39
pubmed: 20690856
Int J Radiat Biol. 2000 Jul;76(7):929-37
pubmed: 10923617
Sci Rep. 2019 Jun 4;9(1):8255
pubmed: 31164689
Int J Radiat Biol. 1989 Apr;55(4):513-29
pubmed: 2564863
J Biol Chem. 2011 Feb 18;286(7):4968-77
pubmed: 21081487
Nat Struct Mol Biol. 2015 Mar;22(3):230-7
pubmed: 25643323
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):776-784
pubmed: 29413288
Mutat Res. 2020 May - Dec;821:111695
pubmed: 32304909
Nature. 2021 Feb;590(7847):660-665
pubmed: 33597753
Radiat Prot Dosimetry. 2019 May 1;183(1-2):60-68
pubmed: 30566664
Mutat Res. 2011 Jun 3;711(1-2):134-41
pubmed: 21130102
Cancers (Basel). 2017 Jun 09;9(6):
pubmed: 28598362
Cell Cycle. 2018;17(21-22):2399-2410
pubmed: 30394812
Mutagenesis. 2008 Mar;23(2):119-29
pubmed: 18267950
Cell Cycle. 2014;13(16):2509-16
pubmed: 25486192
Br J Cancer. 2019 Apr;120(8):779-790
pubmed: 30911090
Mutat Res. 2011 Jun 3;711(1-2):123-33
pubmed: 21185841
Radiat Res. 1996 Apr;145(4):391-407
pubmed: 8600500
Sci Rep. 2021 Oct 21;11(1):20854
pubmed: 34675263
Radiat Res. 2003 Mar;159(3):401-10
pubmed: 12600243
J Biol Chem. 2011 Sep 30;286(39):33845-53
pubmed: 21816818
Nucleic Acids Res. 2006;34(21):6170-82
pubmed: 17088286
Nucleic Acids Res. 2010 Jun;38(10):3245-51
pubmed: 20150414
J Hematol Oncol. 2018 Dec 12;11(1):136
pubmed: 30541578
Radiat Environ Biophys. 1995 Mar;34(1):45-8
pubmed: 7604160
Cancer Res Treat. 2021 Jul;53(3):635-640
pubmed: 34176252
PLoS Genet. 2014 Jan;10(1):e1004086
pubmed: 24453986
Mutat Res. 2010 Aug 14;701(1):52-9
pubmed: 20298802
J Biol Chem. 2016 Nov 18;291(47):24377-24389
pubmed: 27703001
Mol Cell. 2017 Feb 16;65(4):671-684.e5
pubmed: 28132842
PLoS One. 2013;8(3):e59505
pubmed: 23555685
J Radiat Res. 2002 Dec;43 Suppl:S181-5
pubmed: 12793755
Nat Commun. 2021 Dec 8;12(1):7126
pubmed: 34880204
Prog Nucleic Acid Res Mol Biol. 1988;35:95-125
pubmed: 3065826
J Radiat Res. 2009 Jan;50(1):37-42
pubmed: 18957831
Genes Dev. 2001 Dec 15;15(24):3296-307
pubmed: 11751635
Radiat Res. 2013 Jul;180(1):100-9
pubmed: 23682596
Nat Struct Mol Biol. 2010 Jan;17(1):11-6
pubmed: 20051983
Genomics. 1997 Dec 15;46(3):476-9
pubmed: 9441753
Trends Biochem Sci. 2017 Sep;42(9):690-701
pubmed: 28739276
Genes (Basel). 2020 Jan 15;11(1):
pubmed: 31952359
Cancer Res Treat. 2021 Jul;53(3):611-620
pubmed: 34139805
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):603-16
pubmed: 14751534
Radiat Res. 2006 Jan;165(1):59-67
pubmed: 16392963
Radiat Res Suppl. 1985;8:S103-11
pubmed: 3867077
PLoS Genet. 2019 Aug 5;15(8):e1008319
pubmed: 31381562
Nucleic Acids Res. 2018 Apr 20;46(7):3446-3457
pubmed: 29447383
Mutat Res. 2011 Jun 3;711(1-2):100-12
pubmed: 21167187
Int J Mol Sci. 2020 Sep 09;21(18):
pubmed: 32917044
DNA Repair (Amst). 2015 Apr;28:93-106
pubmed: 25659339